MicroRNA-100 functions as a tumor suppressor by inhibiting Lgr5 expression in colon cancer cells

Molecular Medicine Reports

Volumn 11, Issue 4, 2015, Pages 2947-2952

  Zhou, Ming Kai ^a   Liu, Xiao Jun ^a   Zhao, Zhi Guo ^a   Cheng, Yi Meng ^b  

^a ZHENGZHOU UNIVERSITY   (China)

^b Zhengzhou Third People's Hospital   (China)

Author keywords

Colon cancer; G protein coupled receptor 5; MicroRNA; MicroRNA 100; catenin

Indexed keywords

BETA CATENIN; G PROTEIN COUPLED RECEPTOR; LEUCINE RICH REPEAT CONTAINING G PROTEIN COUPLED RECEPTOR 5; MICRORNA 100; UNCLASSIFIED DRUG; WNT PROTEIN; 3' UNTRANSLATED REGION; LGR5 PROTEIN, HUMAN; MICRORNA; MIRN100 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; GAIN OF FUNCTION MUTATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HCT116 CELL LINE; HUMAN; HUMAN TISSUE; LOSS OF FUNCTION MUTATION; PROTEIN EXPRESSION; TUMOR GROWTH; UPREGULATION; WNT SIGNALING PATHWAY; BINDING SITE; CELL MOTION; CELL SURVIVAL; CHEMISTRY; COLON TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; BETA CATENIN; BINDING SITES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MICRORNAS; RECEPTORS, G-PROTEIN-COUPLED; RNA INTERFERENCE;

EID: 84921367730     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.3052     Document Type: Article

References (24)

1. Des Guetz G, Uzzan B, Bouillet T., et al.: Impact of physical activity on cancer-specific and overall survival of patients with colorectal cancer. Gastroenterol Res Pract 2013: 340851, 2013.
2. Søgaard M, Thomsen R.W., Bossen KS, Sørensen HT and Nørgaard M: The impact of comorbidity on cancer survival: a review. Clin Epidemiol 5 (Suppl 1): 3-29, 2013.
3. Chiu BC, Ji BT, Dai Q, Gridley G., McLaughlin JK, Gao YT, Fraumeni JF Jr and Chow WH: Dietary factors and risk of colon cancer in Shanghai, China. Cancer Epidemiol Biomarkers Prev 12: 201-208, 2003.
4. Walker AS, Zwintscher NP, Johnson E.K., Maykel JA, Stojadinovic A, Nissan A, Avital I., Brücher BL and Steele SR: Future directions for monitoring treatment response in colorectal cancer. J Cancer 5: 44-57, 2014.
5. Sun K and Lai EC: Adult-specific functions of animal microRNAs. Nat Rev Genet 14: 535-548, 2013.
6. Ameres SL and Zamore PD: Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol 14: 475-488, 2013.
7. Wu WK, Law PT, Lee C.W., Cho CH, Fan D, Wu K, Yu J and Sung JJ: MicroRNA in colorectal cancer: from benchtop to bedside. Carcinogenesis 32: 247-253, 2011.
8. Kjaer-Frifeldt S, Hansen TF, Nielsen B.S., Joergensen S., Lindebjerg J, Soerensen FB, dePont Christensen R and Jakobsen A: The prognostic importance of miR-21 in stage II colon cancer: a population-based study. Br J Cancer 107: 1169-1174, 2012.
9. Wu W, Yang J, Feng X., Wang H, Ye S, Yang P., Tan W, Wei G and Zhou Y: MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells. Mol Cancer 12: 30, 2013.
10. Yuan K, Xie K, Fox J., Zeng H, Gao H, Huang C and Wu M: Decreased levels of miR-224 and the passenger strand of miR-221 increase MBD2, suppressing maspin and promoting colorectal tumor growth and metastasis in mice. Gastroenterology 145: 853-864, 2013.
11. Schetter AJ, Leung SY, Sohn J.J., Zanetti KA et al.: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-436, 2008.
12. Haegebarth A and Clevers H: Wnt signaling, lgr5, and stem cells in the intestine and skin. Am J Pathol 174: 715-721, 2009.
13. Wilson C: Diabetes: Human β-cell proliferation by promoting Wnt signalling. Nat Rev Endocrinol 9: 502, 2013.
14. Huang J, Gao K, Lin J and Wang Q: MicroRNA-100 inhibits osteosarcoma cell proliferation by targeting Cyr61. Tumour Biol 35: 1095-1100, 2014.
15. Zheng YS, Zhang H, Zhang X.J., Feng DD, et al.: MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia. Oncogene 31: 80-92, 2012.
16. Chen P, Zhao X and Ma L: Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepato-cellular carcinoma. Mol Cell Biochem 383: 49-58, 2013.
17. Liu J, Lu KH, Liu Z L, Sun M, De W and Wang ZX: Micro RNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1. BMC Cancer 12: 519, 2012.
18. Gebeshuber CA and Martinez J: miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling. Oncogene 32: 3306-3310, 2013.
19. Leushacke M and Barker N: Lgr5 and Lgr6 as markers to study adult stem cell roles in self-renewal and cancer. Oncogene 31: 3009-3022, 2012.
20. Fukuma M, Tanese K, Effendi K., Yamazaki K, Masugi Y, Suda M and Sakamoto M: Leucine-rich repeat-containing G protein-c o uple d receptor 5 regulates epithelial cell phenotype and survival of hepato-cellular carcinoma cells. Exp Cell Res 319: 113-121, 2013.
21. Zeki SS, Graham TA and Wright NA: Stem cells and their implications for colorectal cancer. Nat Rev Gastroenterol Hepatol 8: 90-100, 2011.
22. Schuijers J and Clevers H: Adult mammalian stem cells: the role of Wnt, Lgr5 and R-spondins. EMBO J 31: 2685-2696, 2012.
23. Lewis A, Segditsas S, Deheragoda M., et al.: Severe polyposis in Apc(1322T) mice is associated with submaximal Wnt signalling and increased expression of the stem cell marker Lgr5. Gut 59: 1680-1686, 2010.
24. Liu Z, Dai W, Jiang L and Cheng Y: Over-expression of LGR5 correlates with poor survival of colon cancer in mice as well as in patients. Neoplasma 61: 177-185, 2014.